All companies
Visit website
Rhinogram
OperatingRhinogram, Inc
Healthcare · Technology · Founded 2022
Virtual platfom that connects patients with healthcare providers
Post-money valuation ⓘ
$60.1M
As of Oct 2022 · from Reg CF Offering (2022) · pre-money + amount raised, not a traded price
Total raised
$144,250
Across 1 round since 2022
Latest share price
$11.47
Reg CF Offering (2022) offering price
Financials
FY2020–FY2022 · from SEC filings · hover any figure for its source$1.3M
−$7.1M
2020
$1.8M
−$5.6M
2021
$1.6M
−$5.5M
2022
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2020
FY2021
FY2022
Income statement
Revenue
$1,346,238
$1,796,794
$1,639,212
Cost of goods sold
$862,082
$1,072,344
$798,750
Gross margin
36%
40%
51%
Net income
-$7,059,952
-$5,616,085
-$5,490,421
Taxes paid
$0
$0
$0
Balance sheet
Cash
$136,884
$86,086
$87,360
Accounts receivable
$0
$0
$0
Total assets
$4,487,129
$3,112,278
$1,841,196
Short-term debt
$105,000
$14,599,408
$12,081,827
Long-term debt
$13,474,965
$2,179,096
$9,223,916
Total liabilities
$13,579,965
$16,778,504
$21,305,743
Other
Headcount
—
30
30
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$60.1M
post-money
Reg CF Offering (2022)
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $144.2K / $1.1MInvestors 29Post-money $60.1M
Reg CF annual-report compliance
Not requiredFiled Form C-TR (terminated reporting)
Filed 1 of 4 annual reports (FY2022–FY2025)
29 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
Source: ManualCIK 0001935990Share price $11.47
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.